Filling the need for trusted information on national health issues…

Trending on kff Subsidies Marketplaces Enrollment

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Global Vaccine Sales Up 16% In 2009, Report Says

Global vaccine sales “grew by a healthy 16 percent last year, when sales shot up to $22.1 billion, healthcare market research publisher Kalorama Information reported Friday,” according to Associated Press. Kalorama is also forecasting sales “will rise at a compound annual rate of 9.7 percent during the next five years,” (Johnson, 8/14).

Recent Releases In Global Health

Lancet Examines Health Workers Lost To International Organizations A Lancet Comment discusses how developing country doctors and nurses who are recruited by in-country international organizations, research institutions and non-governmental organizations (NGOs) can “prevent government-trained doctors and nurses from contributing to their [national health service] NHS.” The authors write that some of…

Bloomberg BusinessWeek Explores Growing Trend In Pharma To License, Donate HIV Drugs

“Pharmaceutical companies, once blasted as uncaring or downright greedy for charging thousands of dollars for a year’s worth of AIDS medicines … in poor countries, lately have been slashing prices and licensing their drugs for free or nominal cost to nonprofits or local manufacturers in the developing world,” Bloomberg BusinessWeek writes in an analysis piece that examines how this trend, combined with a growing capability among aid agencies to distribute drugs, has the potential to increase access to HIV/AIDS drugs worldwide.

Recent Releases In Global Health

Lancet Comment Calls For More Research Into Alcohol Use, HIV According to a Lancet Comment, “alcohol remains conspicuously absent from the larger field of research and programming in HIV and substance use. … Patterns of hazardous alcohol consumption prevail in countries with the most severe HIV epidemics, notably eastern and…

New York Times Examines India’s Growing Influence On Global Drug Industry

“India, seasoned in the basics of medicine making, is now starting to take on a more mainstream role in the global drug industry, as a result of recent strengthening of patent law here and cost pressures on name-brand drug makers in the West,” the New York Times writes in a piece that examines what the role could mean for the country as well as for the global drug industry.

UNITAID Concerned About Infant HIV Medication Shortage, Drug Company Says Supply Is Sufficient

Bristol-Myers Squibb’s plans this month to close its plant in Meymac, France, that manufactures “the last therapeutic option” for HIV-positive babies has drawn criticism from UNITAID, Reuters reports. In an open letter published in the Lancet (.pdf), UNITAID writes that “[c]losing this factory means that 4,000 to 7,000 babies currently enrolled in treatment plans in developing countries through UNITAID could be left without the medicines they need.”